[go: up one dir, main page]

DK3752507T3 - Triazoloquinazolinon-syntese - Google Patents

Triazoloquinazolinon-syntese Download PDF

Info

Publication number
DK3752507T3
DK3752507T3 DK18849402.5T DK18849402T DK3752507T3 DK 3752507 T3 DK3752507 T3 DK 3752507T3 DK 18849402 T DK18849402 T DK 18849402T DK 3752507 T3 DK3752507 T3 DK 3752507T3
Authority
DK
Denmark
Prior art keywords
triazoloquinazolinone
synthesis
triazoloquinazolinone synthesis
Prior art date
Application number
DK18849402.5T
Other languages
English (en)
Inventor
Thomas Jagusch
Peter Adrianus Hubertus Zenhorst
Der Aa Paula Anna Adriana Van
Govert Arie Verspui
Martin Kas
Martina Scigelova
Original Assignee
Gabather Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gabather Ab filed Critical Gabather Ab
Application granted granted Critical
Publication of DK3752507T3 publication Critical patent/DK3752507T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK18849402.5T 2017-12-19 2018-12-19 Triazoloquinazolinon-syntese DK3752507T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762607353P 2017-12-19 2017-12-19
PCT/IB2018/001573 WO2019123011A1 (en) 2017-12-19 2018-12-19 Triazoloquinazolinone synthesis

Publications (1)

Publication Number Publication Date
DK3752507T3 true DK3752507T3 (da) 2023-01-09

Family

ID=65494446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18849402.5T DK3752507T3 (da) 2017-12-19 2018-12-19 Triazoloquinazolinon-syntese

Country Status (8)

Country Link
US (1) US11434243B2 (da)
EP (1) EP3752507B1 (da)
JP (1) JP7236458B2 (da)
DK (1) DK3752507T3 (da)
ES (1) ES2934885T3 (da)
FI (1) FI3752507T3 (da)
PL (1) PL3752507T3 (da)
WO (1) WO2019123011A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230372348A1 (en) * 2020-10-06 2023-11-23 Gabather Ab Lipid formulations of triazoloquinazolinone compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2288612T3 (pl) 2008-04-04 2015-12-31 Gabather Ab Modulatory receptora GABAA
US10093683B2 (en) 2014-04-22 2018-10-09 Merck Sharp & Dohme Corp. Factor XIa inhibitors
KR102179763B1 (ko) * 2014-04-23 2020-11-17 덕산네오룩스 주식회사 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치

Also Published As

Publication number Publication date
WO2019123011A1 (en) 2019-06-27
PL3752507T3 (pl) 2023-03-13
ES2934885T3 (es) 2023-02-27
US20210087193A1 (en) 2021-03-25
US11434243B2 (en) 2022-09-06
JP2021508342A (ja) 2021-03-04
EP3752507B1 (en) 2022-11-16
JP7236458B2 (ja) 2023-03-09
EP3752507A1 (en) 2020-12-23
FI3752507T3 (fi) 2023-02-16

Similar Documents

Publication Publication Date Title
DK3731771T3 (da) V462033dk00
DE202018003363U8 (de) Handgelenkssphygmomanometer
EP3634404C0 (en) PYRAZOLE-BASED MAGL INHIBITORS
EP3589248A4 (en) CRYOTHERAPIES
LT3645518T (lt) Omekamitivo mekarbilo sintezė
EP3588580A4 (en) SCHOTTKY MOS TRENCH DIODE
DK3351526T3 (da) Diisopentylterephthalat
EP3697802A4 (en) TRITERPENIC SAPONIN ANALOGUES
EP3634397A4 (en) HETEROCYCLYL POLYMETHINE-BASED IR CHROMOPHORES
DK3568655T3 (da) Rekuperator
DK3571580T3 (da) Load-logical-and-shift-guarded-instruktion
DK3612237T3 (da) Genterapi
EP3611402A4 (en) Servo cylinder
EP3714787A4 (en) BIOSENSOR
EP3728590C0 (en) NEW THIOPHOSPHORAMIDITES
DK3576686T3 (da) Brokbind
DK3568506T3 (da) Offeranode
EP3689701A4 (en) BOGIE
FI11704U1 (fi) Liittopuujärjestely
EP3684780C0 (en) SYNTHESIS OF FLOXURIDINE
EP3569893A4 (en) CHAIN TENSIONER
FI11529U1 (fi) Ontelolaatan kannake
DK3676276T3 (da) Spirothietannukleosider
DK3395159T3 (da) Ballepresse
DK3576718T3 (da) Pastil